Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds

[Image: see text] Cannabinoid receptor 1 (CB(1)) is a key drug target for a number of diseases, including metabolic syndromes and neuropathic pain. Most of the typical cannabinoid ligands provoke psychotropic side effects that impair their therapeutic utility. As of today, it is not yet clearly know...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Pharmacol Transl Sci
Autors principals: Wouters, Elise, Walraed, Jolien, Robertson, Michael Joseph, Meyrath, Max, Szpakowska, Martyna, Chevigné, Andy, Skiniotis, Georgios, Stove, Christophe
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2019
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155187/
https://ncbi.nlm.nih.gov/pubmed/32296768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.9b00069
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars